HCPCS code Q2055 — Idecabtagene vicleucel car. Status: Active. Effective Apr 4, 2024. Source: CMS HCPCS Level II.

Q2055

Active

Idecabtagene vicleucel car

Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Apr 4, 2024
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9422

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
59572-0515-01 Abecma
59572-0515-02 Abecma
59572-0515-03 Abecma

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q2
    Idecabtagene vicleucel car